You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site.

Continue

Go back

Welcome to GSK Respiratory

In these pages you can find out about our Ellipta portfolio of medicines. You can also access useful resources for you and your patients and hear expert perspectives on a range of respiratory topics.

Ellipta demonstration device

Demonstration device for healthcare professionals to show patients how to use the Ellipta device correctly.

IMPORTANT: The Ellipta demonstration device is intended for demonstrating only and not for patient use. Patients should not put the demonstration inhaler in their mouth.

NA

ACT - Asthma Contral Test

The Asthma Control Test (ACT) is a simple, easyto-use, patient-administered asthma assessment tool. It is validated and shown to be an accurate measure of asthma symptom control.1 The test can be completed by the atients themselves or in conjunction with a heathcare professional.It allows the patients to “know their asthma score” and can help encourage discussion.

Download here

Reference:

  1. Nathan R, et al. J Allergy Clin Immunol 2004; 113: 59-65

Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255 or via online form https://gsk.public.reportum.com/.

Asthma Control Test (ACT) ©2026 QualityMetric Inc. All rights reserved. ACT is a trademark of QualityMetric Incorporated.

Trade marks are owned by or licensed to the GSK group of companies